Interpretation of China′s fungal infection management policy
10.3760/cma.j.cn101070-20230629-00539
- VernacularTitle:中国真菌感染管理政策解读
- Author:
Jiajia FENG
1
;
Weihua KONG
;
Likai LIN
Author Information
1. 武汉大学医院管理研究所/武汉大学中南医院，武汉 430071
- Keywords:
Fungal infection;
Antifungal agents;
Policy
- From:
Chinese Journal of Applied Clinical Pediatrics
2024;39(1):7-9
- CountryChina
- Language:Chinese
-
Abstract:
Fungal infections are a growing public health threat, especially as the at-risk population for invasive fungal disease expanding and antifungal resistance emerging.In 2022, the World Health Organization released the first fungal priority pathogens list, aiming to encourage countries to strengthen the response to fungal infections.As one of the first countries to issue and implement the National Action Plan to Contain Antimicrobial Resistance in the world, China has attached great importance to the management of fungal infections.A series of actions and efforts have been made, including improving the legal and regulatory system related to the prevention and treatment of fungal infections, strengthening the management of clinical application of antifungal drugs, improving the diagnosis and treatment ability of fungal infections and the standardization of diagnosis and treatment, establishing a monitoring and evaluation system for fungal infections and drug resistance.Initial results have been achieved.In the future, under the guidance of the new national action plan to contain antimicrobial resistance, the level of diagnosis and treatment of fungal infections will be further improved to reduce the occurrence of fungal infections and the spread of antifungal resistance.
